Uniphar Group PLC

IR:UPR Ireland Medical Distribution
Market Cap
$1.06 Billion
€1.03 Billion EUR
Market Cap Rank
#7422 Global
#2 in Ireland
Share Price
€3.96
Change (1 day)
-1.12%
52-Week Range
€2.52 - €4.21
All Time High
€4.96
About

Uniphar plc, together with its subsidiaries, operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, the Netherlands, and internationally. It operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. The company provides sales, marketing, compliance, and distribution services to medical device manufacturers;… Read more

Uniphar Group PLC (UPR) - Net Assets

Latest net assets as of June 2025: €372.98 Million EUR

Based on the latest financial reports, Uniphar Group PLC (UPR) has net assets worth €372.98 Million EUR as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€1.56 Billion) and total liabilities (€1.19 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets €372.98 Million
% of Total Assets 23.93%
Annual Growth Rate N/A
5-Year Change 98.43%
10-Year Change N/A
Growth Volatility 4.27

Uniphar Group PLC - Net Assets Trend (2016–2024)

This chart illustrates how Uniphar Group PLC's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Uniphar Group PLC (2016–2024)

The table below shows the annual net assets of Uniphar Group PLC from 2016 to 2024.

Year Net Assets Change
2024-12-31 €401.88 Million +20.46%
2023-12-31 €333.62 Million +15.13%
2022-12-31 €289.78 Million +15.19%
2021-12-31 €251.56 Million +24.21%
2020-12-31 €202.53 Million +11.95%
2019-12-31 €180.92 Million +21.50%
2018-12-31 €148.90 Million +1488.73%
2017-12-31 €-10.72 Million -5.14%
2016-12-31 €-10.20 Million --

Equity Component Analysis

This analysis shows how different components contribute to Uniphar Group PLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 22948700000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings €188.62 Million 46.95%
Other Components €213.14 Million 53.05%
Total Equity €401.75 Million 100.00%

Uniphar Group PLC Competitors by Market Cap

The table below lists competitors of Uniphar Group PLC ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Uniphar Group PLC's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 332,802,000 to 401,755,000, a change of 68,953,000 (20.7%).
  • Net income of 64,203,000 contributed positively to equity growth.
  • Dividend payments of 5,076,000 reduced retained earnings.
  • Other factors increased equity by 9,826,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income €64.20 Million +15.98%
Dividends Paid €5.08 Million -1.26%
Other Changes €9.83 Million +2.45%
Total Change €- 20.72%

Book Value vs Market Value Analysis

This analysis compares Uniphar Group PLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.69x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2016-12-31 €-0.04 €3.96 x
2017-12-31 €-0.04 €3.96 x
2018-12-31 €0.55 €3.96 x
2019-12-31 €0.99 €3.96 x
2020-12-31 €0.77 €3.96 x
2021-12-31 €0.96 €3.96 x
2022-12-31 €1.06 €3.96 x
2023-12-31 €1.22 €3.96 x
2024-12-31 €1.47 €3.96 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Uniphar Group PLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 15.98%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 2.32%
  • • Asset Turnover: 1.96x
  • • Equity Multiplier: 3.52x
  • Recent ROE (15.98%) is above the historical average (11.25%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2016 0.00% 0.44% 4.51x 0.00x €6.76 Million
2017 0.00% -0.08% 4.38x 0.00x €17.10K
2018 11.60% 1.11% 2.37x 4.39x €2.39 Million
2019 11.60% 1.26% 2.19x 4.20x €2.91 Million
2020 13.74% 1.53% 2.17x 4.15x €7.58 Million
2021 19.12% 2.47% 2.06x 3.76x €22.93 Million
2022 15.74% 2.20% 1.86x 3.84x €16.63 Million
2023 13.47% 1.76% 1.98x 3.87x €11.53 Million
2024 15.98% 2.32% 1.96x 3.52x €24.03 Million

Industry Comparison

This section compares Uniphar Group PLC's net assets metrics with peer companies in the Medical Distribution industry.

No peer company data available for comparison.